CrushSCI.com
106.4Average days
91.5Median days
7Fastest days
225Longest days
5962025 publications

Paper Review Records

All Paper Review Records

28 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

33 days

Practical Transfusion Medicine7th Edition Edited by Michael F.Murphy, Nancy M.Dunbar and Erica M.Wood, Wiley. 2026. ISBN‐10: 1394291965

Authors
Sue Pavord; Julie StavesShow moreShow less
Affiliations
1. Department of Haematology Oxford University Hospitals NHS Foundation Trust Oxford UKShow moreShow less
Source PDF DOI Publisher page
73 days

Complex karyotype and non‐ BTK driver mutations associated with BTK inhibitor resistance in chronic lymphocytic leukaemia

Authors
Kiyomi Mashima; Stacey M. Fernandes; Mariia Mikhaleva; Roberta Santos Azevedo; Stephen Martindale; Binu Kandathilparambil Sasi; Saurabh Yadav; Uday Aditya Sarkar; Rayan Fardoun; Xinhao Sun; Colin McNulty; Ava M. Kominski; Paige R. Fitzgerald; Ava Bidgoli; Paulina Predko; Samantha Shupe; John‐Hanson Machado; Aishath Naeem; Inhye E. Ahn; Matthew S. Davids; Jennifer R. BrownShow moreShow less
Affiliations
1. Department of Medical Oncology, CLL Center Dana‐Farber Cancer Institute Boston Massachusetts USA; 2. Department of Medicine Harvard Medical School Boston Massachusetts USAShow moreShow less
Source PDF DOI Publisher page
128 days

CD20 antigen loss post‐venetoclax/anti‐ CD20 therapy in chronic lymphocytic leukaemia: Frequency, characteristics and potential therapeutic implications

Authors
Tamasine Stewart; Sean McKeague; Divya Somasekharannair; Lei‐Shong Lau; Ashley Whitechurch; Joshua Casan; Neil Came; Kylie Baldwin; Vuong Nguyen; Ing Soo Tiong; Sean Harrop; Mary Ann Anderson; John F. Seymour; David Westerman; Philip A. Thompson; Kah Lok ChanShow moreShow less
Affiliations
1. Department of Pathology Peter MacCallum Cancer Centre Melbourne Victoria Australia; 2. Department of Clinical Haematology Peter MacCallum Cancer Centre and Royal Melbourne Hospital Melbourne Victoria Australia; 3. Department of Haematology Royal Brisbane and Women's Hospital Brisbane Queensland Australia; 4. Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne Victoria Australia; 5. School of Nursing and Midwifery La Trobe University Melbourne Victoria AustraliaShow moreShow less
Source PDF DOI Publisher page
135 days

Spatial and transcriptomic analyses reveal the adverse prognostic impact of regulatory T cells in follicular lymphoma treated with rituximab–lenalidomide

Authors
Camille Laurent; Marie Tosolini; Arnaud Guille; Bruno Tesson; Nathalie Van‐Acker; François‐Xavier Frenois; Andrea Belin‐Artola; Bastien Lesne; Pierre Brousset; BIDIFLY Consortium; Franck Morschhauser; Luc XerriShow moreShow less
Affiliations
1. Laboratoire d'Excellence TOUCAN, Centre de Recherches en Cancérologie de Toulouse INSERM U1037, Institut Universitaire Cancer‐Oncopole, CHU Toulouse Toulouse France; 2. Institut Paoli‐Calmettes, CRCM and Aix‐Marseille University Marseille France; 3. LYSARC Pierre Bénite France; 4. Hopital Claude Huriez Lille FranceShow moreShow less
Source PDF DOI Publisher page
175 days

A real‐time text‐based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study

Authors
Victor Tellez; Anirvin Bommaraju; Jamie Cheung; Regina Swift; Jonathan Moore; Pierre Sayad; Frank Pezzullo; Aaron Gette; Alex Wright; Jon Hall; Randall Noval; Blake Morrison; James R. BerensonShow moreShow less
Affiliations
1. Berenson Cancer Center West Hollywood California USA; 2. Institute for Myeloma & Bone Cancer Research West Hollywood California USA; 3. mQOL San Jose California USAShow moreShow less
Source PDF DOI Publisher page
166 days

Temporal trends in infectious risk among multiple myeloma patients treated with daratumumab: A meta‐analysis

Authors
Alissa Visram; Hira Mian; James Lee; Aaron Jones; Gregory R. Pond; Doris Hansen; Surbhi Sidana; Luciano J. CostaShow moreShow less
Affiliations
1. Juravinski Cancer Centre Hamilton Health Sciences Hamilton Ontario Canada; 2. Department of Oncology, McMaster University Hamilton Ontario Canada; 3. ICES McMaster University Hamilton Ontario Canada; 4. Department of Health Research Methods, Evidence, and Impact McMaster University Hamilton Ontario Canada; 5. H. Lee Moffitt Cancer Centre & Research Institute Tampa Florida USA; 6. Division of Blood and Marrow Transplantation and Cellular Therapy Stanford University Stanford California USA; 7. Division of Hematology and Oncology, Department of Medicine University of Alabama at Birmingham Birmingham Alabama USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does BRITISH JOURNAL OF HAEMATOLOGY take to review a manuscript?

As of 2026-11-17, CrushSCI has 28 complete review records for BRITISH JOURNAL OF HAEMATOLOGY. The fastest paper went from submission to acceptance in 7 days (The speed of sequencing: Rapid molecular testing in acute myeloid leukaemia, received 2026-10-06, accepted 2026-10-13); the slowest took 225 days. The average is 106.4 days and the median is 91.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.